Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Oct 31;17(10):9039-9050.
doi: 10.21037/jtd-2025-1445. Epub 2025 Oct 29.

Real-world oncologic outcomes of thoracoscopic and open tracheal cancer resection

Affiliations

Real-world oncologic outcomes of thoracoscopic and open tracheal cancer resection

Alexander Pohlman et al. J Thorac Dis. .

Abstract

Background: Minimally invasive video-assisted thoracoscopic surgery (VATS) for tracheal cancer is gaining popularity. However, data are limited to single-center reports and short-term outcomes. In this context, we aim to compare short and long-term oncologic outcomes of VATS versus open tracheal cancer resection at the national level.

Methods: We used a national dataset to isolate primary tracheal cancers diagnosed between 2010-2021. Patients were stratified by operative approach into open and VATS resection groups. Cox analysis was used to estimate proportional effects of covariates in unmatched cohorts. We then used propensity score matching to minimize confounding bias from covariates. Kaplan-Meier survival analyses were used to estimate 5-year survival.

Results: Of 331 patients undergoing tracheal cancer resection, 147 (44.4%) were started VATS with 5 (3.4%) converting to open. Patients undergoing VATS tracheal resection were similar in age (62.4±14.5 vs. 59.9±14.2 years; P=0.12), race (White =81.0% vs. 84.8%; P=0.32) and Charlson-Deyo comorbidity (index =0, 59.2% vs. 68.5%; P=0.19), but were more likely to be male (57.8% vs. 46.2%; P=0.04) and have positive margins (58.1% vs. 41.0%; P=0.006) compared to open resection. Post-operative length of stay was shorter with VATS (median 2.5 vs. 7.0 days; P<0.001), but this came at the expense of higher rates of positive margins [adjusted odds ratio (aOR) =2.15, P=0.02] and worse median survival (74 vs. 106 months; P<0.001), which persisted after matching (79 vs. 100 months; P=0.01).

Conclusions: In this national observational study, we found that the short-term benefits of thoracoscopic tracheal resection come at the expense of increased positive margins and worse survival. Adoption of this approach for tracheal cancer should be met with caution.

Keywords: Tracheal cancer; open surgery; video-assisted thoracoscopic surgery (VATS).

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-2025-1445/coif). Z.M.A. serves as an unpaid editorial board member of Journal of Thoracic Disease from December 2023 to November 2025. The other authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Consort diagram for creation of study cohort. NCDB, National Cancer Database; PSM, propensity score match; VATS, video-assisted thoracoscopic surgery.
Figure 2
Figure 2
Adjusted probability of achieving negative resection margins stratified by approach across tracheal tumor size. This multivariable model adjusts for age, sex, race, ethnicity, comorbidities, insurance status, facility type, center volume, tumor size, histology, and extension of disease. R0: negative resection margin. VATS, video-assisted thoracoscopic surgery.
Figure 3
Figure 3
Open versus minimally invasive tracheal resection Kaplan-Meier survival curves. (A) All histology. (B) Squamous cell carcinoma. (C) Adenoid cystic carcinoma. (D) Other histology. VATS, video-assisted thoracoscopic surgery.
Figure 4
Figure 4
Cox proportional hazards model in the unmatched cohort. *, interaction term. CDI, Charlson-Deyo index; VATS, video-assisted thoracoscopic surgery.
Figure 5
Figure 5
Propensity score matched Kaplan-Meier survival curve. VATS, video-assisted thoracoscopic surgery.

References

    1. Shah P, Kela K, Hegde UP. Tracheal cancer epidemiology and survival trends: A SEER database analysis. J Clin Oncol 2024;42:e20078.
    1. Piórek A, Płużański A, Teterycz P, et al. Do We Need TNM for Tracheal Cancers? Analysis of a Large Retrospective Series of Tracheal Tumors. Cancers (Basel) 2022;14:1665. 10.3390/cancers14071665 - DOI - PMC - PubMed
    1. Nilssen Y, Solberg S, Brustugun OT, et al. Tracheal cancer: a rare and deadly but potentially curable disease that also affects younger people. Eur J Cardiothorac Surg 2023;64:ezad244. 10.1093/ejcts/ezad244 - DOI - PMC - PubMed
    1. Hazama K, Miyoshi S, Akashi A, et al. Clinicopathological investigation of 20 cases of primary tracheal cancer. Eur J Cardiothorac Surg 2003;23:1-5. 10.1016/s1010-7940(02)00728-5 - DOI - PubMed
    1. Benissan-Messan DZ, Merritt RE, Bazan JG, et al. National Utilization of Surgery and Outcomes for Primary Tracheal Cancer in the United States. Ann Thorac Surg 2020;110:1012-22. 10.1016/j.athoracsur.2020.03.048 - DOI - PMC - PubMed

LinkOut - more resources